WASHINGTON: Merck’s anti-Covid pill remains “active” against the Omicron variant, the US drugmaker said Friday (Jan 28), citing results from six laboratory studies. Read full story
WASHINGTON: Merck’s anti-Covid pill remains “active” against the Omicron variant, the US drugmaker said Friday (Jan 28), citing results from six laboratory studies. Read full story